We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Transcatheter tricuspid valve replacement using the ...

Edwards Lifesciences has received US Food and Drug Administration (FDA) approval for its Evoque tricuspid valve replacement system, which becomes the first transcatheter therapy to be approved in the ...

Expert advisors to the US Food and Drug Administration offered little in the way of pushback against the TriClip (Abbott) transcatheter edge-to-edge repair (TEER) system as a treatment for symptomatic ...

Patients with tricuspid regurgitation, a common and debilitating form of valvular heart disease, who received a novel investigational device intended to repair the defective valve experienced ...

Tricuspid valve regurgitation is leaking from your lower heart chamber (ventricle) to your upper heart chamber (atrium) on the right side of your heart. Typically, your tricuspid valve opens and ...

The tricuspid valve forms the boundary between the right ventricle and the right atrium. Deoxygenated blood enters the right side of the heart via the inferior and superior vena cava. These are large ...

Real-world data accumulated in Europe outside of a clinical trial support both the safety and the benefit of two transcatheter edge-to-edge (TEER) devices designed specifically for the treatment of ...

DENVER, CO—Two new transcatheter treatments for severe or greater functional tricuspid regurgitation (TR) are showing good efficacy and safety through 30 days, according to early feasibility study ...

U.S. patients suffering from a leaky tricuspid valve, or tricuspid regurgitation (TR), have more treatment options than ever before, thanks to two significant FDA approvals. FDA has approved Abbott’s ...

The FDA approved the Evoque tricuspid valve replacement system as the first transcatheter treatment for tricuspid regurgitation (TR), Edwards Lifesciences announced. Evoque gained an indication for ...

Patients with leaking tricuspid valves in a research trial saw improvements with a procedure that does not require a risky open-heart surgery. By Gina Kolata For the first time, patients with damaged ...

Adults undergoing mitral valve surgery who have less than severe leakage of the tricuspid valve may benefit by having both valves repaired at the same time, including a decreased chance of severe ...